Literature DB >> 29799973

A Novel Strategy for Increasing Access to Treatment for Hepatitis C Virus Infection for Medicaid Beneficiaries.

Neeraj Sood1, Diane Ung2, Anil Shankar2, Brian L Strom3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29799973     DOI： 10.7326/M18-0186

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

Review 1.  Closing the hepatitis C treatment gap: United States strategies to improve retention in care.

Authors:  Austin T Jones; Christopher Briones; Torrence Tran; Lisa Moreno-Walton; Patricia J Kissinger
Journal:  J Viral Hepat       Date:  2022-05-26       Impact factor: 3.517

2.  The Ethics of Precision Rationing: Human Genetics and the Need for Debate on Stratifying Access to Medication.

Authors:  Alexis Walker; Angie Boyce; Priya Duggal; Chloe L Thio; Gail Geller
Journal:  Public Health Genomics       Date:  2020-06-09       Impact factor: 2.000

3.  Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan.

Authors:  Yueran Zhuo; Tomoyuki Hayashi; Qiushi Chen; Rakesh Aggarwal; Yvan Hutin; Jagpreet Chhatwal
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

4.  The Payer License Agreement, or "Netflix model," for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition.

Authors:  David W Matthews; Samantha Coleman; Homie Razavi; Jean-Manuel Izaret
Journal:  Liver Int       Date:  2022-03-26       Impact factor: 8.754

5.  Machine learning models to predict disease progression among veterans with hepatitis C virus.

Authors:  Monica A Konerman; Lauren A Beste; Tony Van; Boang Liu; Xuefei Zhang; Ji Zhu; Sameer D Saini; Grace L Su; Brahmajee K Nallamothu; George N Ioannou; Akbar K Waljee
Journal:  PLoS One       Date:  2019-01-04       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.